PAX-5 (BSAP) Antibody, anti-human/mouse, REAfinity™
Synonyms: ALL3, BSAP, EBB-1, KLP
RECOMBINANT EXTENDED VALIDATION
Bioz Star94/100 Bioz rating
3 Citations
Clone:
REA140 | 1H9
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
ICFC, MICS, IF, IHC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:
Select a size:
Other sizes

Related products for PAX-5 (BSAP) Antibody, anti-human/mouse, REAfinity™

Intracellular flow cytometry applications
APC
PE
PE-Vio 770
PerCP-Vio 700
Recommended dilution:
1:50
Remark:
The antibody is suited for staining of formaldehyde-fixed cells.
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-131-892, 130-131-961
Description:
Human peripheral blood mononuclear cells (PBMCs) were stained with CD20 antibodies. Cells were then fixed and permeabilized with the FoxP3 Staining Buffer Set, stained with Anti-PAX-5 (BSAP) antibodies, and analyzed by flow cytometry using the MACSQuant® Analyzer. The specificity of the conjugated antibodies was confirmed by blocking the binding to the ligand, using pure unconjugated antibodies (left images). Cell debris were excluded from the analysis based on scatter signals.

Application imageView details view details

Application imageView details view details
Recommended dilution:
1:11
Remark:
The antibody is suited for staining of formaldehyde-fixed cells.
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-099-938, 130-099-936
Description:
Human peripheral blood mononuclear cells (PBMCs) were stained with CD20 antibodies. Cells were then fixed and permeabilized with the FoxP3 Staining Buffer Set, stained with Anti-PAX-5 (BSAP) antibodies, and analyzed by flow cytometry using the MACSQuant® Analyzer. The specificity of the conjugated antibodies was confirmed by blocking the binding to the ligand, using pure unconjugated antibodies (left images). Cell debris were excluded from the analysis based on scatter signals.

Application imageView details view details

Application imageView details view details
MICS (MACSima Imaging Cyclic Staining) applications
APC
PE
Fixation:
FFPE
Species tested:
human
Recommended dilution:
1:11
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
APC
Used products:
130-099-938, 130-099-936
Testing grade:
Fixation:
FFPE
Species tested:
human
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
APC
Used products:
130-131-892, 130-131-961
Testing grade:
Product data and images for PAX-5 (BSAP) Antibody, anti-human/mouse, REAfinity™
Figure 1

Human peripheral blood mononuclear cells (PBMCs) were stained with CD20 antibodies. Cells were then fixed and permeabilized with the FoxP3 Staining Buffer Set, stained with Anti-PAX-5 (BSAP) antibodies, and analyzed by flow cytometry using the MACSQuant® Analyzer. The specificity of the conjugated antibodies was confirmed by blocking the binding to the ligand, using pure unconjugated antibodies (left images). Cell debris were excluded from the analysis based on scatter signals.

Extended validation for PAX-5 (BSAP) Antibody, anti-human/mouse, REAfinity™
Specificity
Epitope competition assay

In order to compare the epitope specificity of an antibody, the clone being used is compared with other known clones recognizing the same antigen in a competition assay.

Other clones
Overlap in epitope recognition with REA140
1H9
high

Cells were incubated with an excess of purified unconjugated PAX-5 (BSAP) (REA140) antibody followed by staining with fluorochrome-conjugated antibodies from other known clones targeting the same antigen. Fluorescence intensity was then used to assess epitope overlap: a minimal or absent signal indicated high epitope overlap, an intermediate signal suggested partial overlap, and a strong signal reflected low overlap.

Specifications for PAX-5 (BSAP) Antibody, anti-human/mouse, REAfinity™
Overview

Clone REA140 recognizes PAX-5, which belongs to the paired box (PAX) gene family of transcription factors. PAX-5 is the only mammalian PAX transcription factor, which is expressed in hematopoietic cells. Within the hematopoietic cells, expression of PAX-5 is limited to cells of the B-lymphocyte lineage and it exerts transcriptional control of B cell commitment, development, and tumorigenesis. PAX-5 contains DNA binding conserved ‘paired’ domain, which consists of an N- and a C-terminal subdomain. Each subregion contains a homeodomain-like helix-turn-helix motif, which binds to a half-site of the PAX-5 recognition sequence. Depending upon the interaction partners, PAX-5 serves either as an activator or repressor of transcription. For instance, Groucho protein family members, by binding to a conserved octapeptide motif of PAX-5, enable PAX-5 to serve as a repressor.

Additional information: Clone REA140 displays negligible binding to Fc receptors.

Alternative names

ALL3, BSAP, EBB-1, KLP

Detailed product information

Technical specifications

Clone
REA140
Clonality
monoclonal
Isotype
recombinant human IgG1
Isotype control
REA Control Antibody (I), human IgG1
Host
human cell line
Type of antibody
Primary antibodies, Recombinant antibodies
Species reactivity
human, mouse
Antigen
PAX-5 (BSAP)
Distribution of antigen
B cells
Entrez Gene ID
RRID
AB_2653164, AB_2653162, AB_2653165, AB_2653163, AB_2928793, AB_2889727, AB_2653160, AB_2653161, AB_2928794, AB_2889726

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for PAX-5 (BSAP) Antibody, anti-human/mouse, REAfinity™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

You have previously chosen International as your location.
What do you want to do?